نتایج جستجو برای: iodixanol

تعداد نتایج: 310  

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1999
P B Jacobsen A Larsen R Konarboland T Skotland

Liposomes loaded with the nonionic iodinated contrast agent iodixanol were injected i.v. into monkeys, rats, and dogs, and liver samples were analyzed by HPLC and mass spectrometry. Two metabolites (M1 and M2), with UV spectra identical to those of the iodixanol isomers (exo and endo) and with a mass increase of 162 compared with iodixanol, were detected. Incubations of iodixanol-liposomes or i...

Journal: :iranian journal of radiology 0
farideh gharekhanloo department of radiology, besat hospital, hamedan university of medical sciences, iran +98-8112640064, [email protected]; department of radiology, besat hospital, hamedan university of medical sciences, iran +98-8112640064, [email protected] saadat torabian department of community medicine, hamedan university of medical sciences, iran

background iodinated x-ray contrast media are the most commonly used contrast agents in the world with an annual application of 40-50 million. new non-ionic con- trast agents are subdivided into low osmolar agents such as iopromide and iso-osmolar agents such as iodixanol. regarding different biochemical characteristics, these agents are different in the allergic reactions and contrast enhancem...

Journal: :Kidney international 2006
P Liss P B Persson P Hansell B Lagerqvist

We compared the Swedish Coronary Angiography and Angioplasty Registry with the Swedish 'Hospital Discharge Register' to assess contrast media (CM)-induced renal failure. Hospitals used only one type CM. From 2000 to 2003, iodixanol (iso-osmolar) was used in 45 485 patients, ioxaglate (low osmolar) in 12 440 subjects. To include the earlier used CM iohexol (low osmolar), analysis extended back t...

Journal: :Circulation. Cardiovascular interventions 2010
Aaron M From Firas J Al Badarin Furman S McDonald Brian J Bartholmai Stephen S Cha Charanjit S Rihal

BACKGROUND Contrast-induced nephropathy (CIN) is associated with significant morbidity and mortality. The objective of our meta-analysis was to assess the efficacy of iodixanol compared with low-osmolar contrast media (LOCM) for prevention of CIN. METHODS AND RESULTS We searched MEDLINE, the Cochrane Central Register of Controlled Trials, and internet sources of cardiology trial results for i...

Journal: :The American journal of cardiology 1994
J A Hill M B Cohen W H Kou G B Mancini M Mansour H Fountaine J A Brinker

Iodixanol, a new ratio 6 nonionic iodinated contrast agent with an osmolality equal to serum, was compared with iohexol in a randomized, double-blind, parallel study. Two hundred patients undergoing elective diagnostic cardiac angiography were randomized to iodixanol (n = 101) or iohexol (n = 99). There were no differences noted between the 2 agents in the mean changes in systolic or diastolic ...

Journal: :American heart journal 2008
Michael R Rudnick Charles Davidson Warren Laskey J Lawrence Stafford Paul F Sherwin

BACKGROUND Iso-osmolar contrast medium iodixanol has been reported to be less nephrotoxic than selected low-osmolar contrast media (LOCM) in chronic kidney disease (CKD) patients with diabetes mellitus. This study compared the nephrotoxicity of iodixanol and the LOCM ioversol in CKD patients undergoing coronary angiography. METHODS This is a prospective double-blind trial in 337 patients with...

2017
Gabriel Hertig Matthias Zehnder Anna Woloszyk Thimios A. Mitsiadis Anja Ivica Franz E. Weber

The application of biomaterials used in regenerative endodontics should be traceable. In this study, we checked some basic effects of rendering a fibrin hydrogel radiopaque using an iodine-based contrast agent (iodixanol) approved for systemic application. Fibrin hydrogels were prepared from a fibrin sealant (Tisseel) using either an isotonic iodixanol solution (Visipaque 320, test) or Tris buf...

Journal: :The European respiratory journal 2002
J Kesecioglu M J Schultz J J Haitsma G J den Heeten B Lachmann

Optimal alveolar distribution of exogenous surfactant is an important determinant of its beneficial effect. This distribution can be determined by suspending surfactant in a radiological contrast medium before intratracheal instillation, followed by radiological imaging. Iodixanol is reported to be a safe contrast medium that causes no lung injury when instilled intratracheally. In this study, ...

2003
Gi Hyeon Kim Byung Kook Kwak Hyung Jin Shim Wei Chiang Liu Seung Hoon Ryu Yang Soo Kim Jong Beum Lee

Purpose: To determine the hepatic and vascular enhancement profiles with nonionic dimeric, iodixanol, contrast agent in the rabbit and to compare them with nonionic monomeric, ioversol, contrast agent. Materials and Methods: Seven rabbits initially underwent hepatic dynamic CT scan with either iodixanol or ioversol, followed by repeated CT scan with other unused contrast agent with one week int...

2018
Xiao-fang Han Xin-xiu Zhang Ke-mei Liu Hua Tan Qiu Zhang

PURPOSE This study was conducted to compare iso-osmolar contrast medium, iodixanol, with low-osmolar contrast media (LOCM) for assessing contrast-induced nephropathy (CIN) incidence, exclusively in the diabetic population. METHOD A systematic search was conducted for full-text, prospective, randomized controlled trials (RCTs). The primary outcome was incidence of CIN. Medline, Cochrane Centra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید